<DOC>
	<DOCNO>NCT01489943</DOCNO>
	<brief_summary>The purpose study test effect study drug ( GSK1605786 ) blood level multiple commonly use drug give measure liver break study drug . These commonly-used drug midazolam , pioglitazone , omeprazole , rosuvastatin determine effect GSK1605786 body break ( metabolizes ) commonly-used drug . Blood sample pharmacokinetic analysis GSK1605786 , two metabolite , [ GSK2635622 ( CCX062 ) GSK2656694 ( CCX304 ) ] four probe substrate collect 24-hour period administration . Safety assess measurement vital sign , cardiac monitoring , collection adverse event assessment laboratory test .</brief_summary>
	<brief_title>A Study Investigate Effect GSK1605786 Hepatic Cytochrome P450 , BCRP OATP1B1 Transport Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Aspartate transaminase , alanine transaminase , alkaline phosphatase bilirubin less equal 1.5x upper limit normal ( isolated bilirubin &gt; 1.5x upper limit normal acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter outside reference range population study may include opinion Investigator find unlikely introduce additional risk factor interfere study procedure . Male female 18 55 year age inclusive , time signing informed consent . A female subject eligible participate ; nonchildbearing potential define premenopausal female document tubal ligation hysterectomy ; postmenopausal define 12 month spontaneous amenorrhea [ questionable case blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 MlU/ml estradiol &lt; 40 pg/ml ( &lt; 147 pmol/L ) confirmatory ] . Body weight equal 60 kg BMI within range 19 30 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form ( include participation pharmacogenetics research ) . QTc &lt; 450 msec ; QTc &lt; 480 msec subject Bundle Branch Block . A positive prestudy Hepatitis B surface antigen Hepatitis B core antibody positive Hepatitis C antibody result within 3 month screen Current illness disability may affect interpretation clinical data , otherwise contraindicate participation clinical study ( e.g. , unstable cardiovascular , autoimmune , renal , hepatic , pulmonary , endocrine , metabolic , gastrointestinal , haematologic , neurological condition mental impairment ) Current preexist condition interfere normal gastrointestinal anatomy motility , hepatic renal function , could interfere absorption , metabolism , excretion study drug ; include limit liver disease know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . A positive test HIV antibody . History regular alcohol consumption within 6 month study define average weekly intake &gt; 14 drink male &gt; 7 drink female . One drink equivalent 12 g alcohol : 12 ounce ( 360 ml ) beer , 5 ounce ( 150 ml ) wine 1.5 ounce ( 45 ml ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort [ Hypericum perforatum ] , kava , ephedra [ huang ] , gingko biloba , DHEA , vohimbe , saw palmetto , panaz ginseng , red yeast rice ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication duration study , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . Herbal medication include , limited : traditional Chinese , Korean Japanese medicine , Panaz ginseng , Gingko biloba St John 's wort ( Hypericum perforatum ) Traditional Chinese herbal medicine ( TCM ) South Asian Ayurvedic medicine , Traditional Korean Medicines Japanese Kampo . Use aspirin , aspirincontaining compound , salicylate nonsteroidal antiinflammatory drug ( NSAIDs ) within 48 hour first dose unwilling abstain use medication last pharmacokinetic sample collect . Use liquid antacid ( e.g . Maalox , Mylanta , Amphogel , milk magnesia ) tablet ( include chewable ) antacid ( e.g . TUMSâ„¢ ) within 48 hour first dose unwilling abstain use medication last dose study medication . Use digoxin related cardiac glycoside ( e.g digitoxin , deslanoside , lanatoside C , metildigoxin ) within 7 day prior screen throughout study . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Pregnant female determine positive serum hCG test screen prior dosing . Lactating female . Unwillingness inability follow procedure outline protocol . Subject mentally legally incapacitate . History sensitivity heparin heparininduced thrombocytopenia . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . This include chew tobacco , Gutka , handrolled tobacco cigarette , Biddis , cigar , Snuff . Use caffeine theobrominecontaining beverage ( e.g. , coffee , tea , certain cola , green tea oolong tea , Yerba Mate , Guarana , South American cocoa ) food ( e.g. , chocolate ) , alcoholcontaining beverage within 72 hour prior dose Consumption red wine , seville orange , grapefruit grapefruit juice , pummelo , exotic citrus fruit , grapefruit hybrid , fruit juice blend , apple orange juice , vegetables mustard green family [ e.g. , kale , broccoli , watercress , collard green , kohlrabi , Brussels sprout , mustard ] charbroiled meat 7 day prior first dose study medication . Confirmed diagnosis coeliac disease , follow glutenfree diet manage symptom suspect coeliac disease subject positive serologic test tissue Transglutaminase , tTG ( screen undiagnosed coeliac disease ) . Active latent tuberculosis ( TB ) infection : All subject test TB skin test ( Mantoux test ) positive test result exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>